Monique J. Roobol

Research interests

Publications

• Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

  Nature Reviews Urology · 2022 · https://doi.org/10.1038/s41585-022-00638-6

• Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

  European Urology · 2021 · https://doi.org/10.1016/j.eururo.2021.07.024

• An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

  Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-17673-9

• An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk

  Nature Communications · 2020 · https://doi.org/10.1038/s41467-020-17673-9

• EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)

  European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.09.020

• Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis

  European Urology · 2019 · 10.1016/j.eururo.2019.06.023

• A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer

  European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.02.009

• Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer

  Cochrane Database of Systematic Reviews · 2019 · 10.1002/14651858.cd012663.pub2

• Reporting and Interpreting Decision Curve Analysis: A Guide for Investigators

  European Urology · 2018 · 10.1016/j.eururo.2018.08.038

• MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1801993

• Large-scale transcriptome-wide association study identifies new prostate cancer risk regions

  Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-06302-1

• Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials

  Annals of Internal Medicine · 2017 · https://doi.org/10.7326/m16-2586

• A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment

  European Urology · 2016 · 10.1016/j.eururo.2016.06.007

• A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

  Cancer Research · 2016 · https://doi.org/10.1158/0008-5472.can-15-1551

• Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

  The Lancet · 2014 · https://doi.org/10.1016/s0140-6736(14)60525-0

• Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes

  BMJ · 2014 · 10.1136/bmj.g1502

• Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis

  European Urology · 2014 · 10.1016/j.eururo.2014.11.037

• Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care

  European Urology · 2012 · https://doi.org/10.1016/j.eururo.2012.09.033

• Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study

  European Urology · 2012 · https://doi.org/10.1016/j.eururo.2012.11.005

• Prostate-Cancer Mortality at 11 Years of Follow-up

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1113135

• Quality-of-Life Effects of Prostate-Specific Antigen Screening

  New England Journal of Medicine · 2012 · 10.1056/nejmoa1201637

• Infectious Complications and Hospital Admissions After Prostate Biopsy in a European Randomized Trial

  European Urology · 2012 · 10.1016/j.eururo.2011.12.058

• Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

  European Urology · 2012 · 10.1016/j.eururo.2012.05.068

• Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.24.1968

• A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial

  The Journal of Urology · 2010 · 10.1016/j.juro.2010.08.082

• Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection

  European Urology · 2010 · 10.1016/j.eururo.2010.02.003

• Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

  European Urology · 2009 · https://doi.org/10.1016/j.eururo.2009.07.018

• Screening and Prostate-Cancer Mortality in a Randomized European Study

  New England Journal of Medicine · 2009 · https://doi.org/10.1056/nejmoa0810084

• A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer

  European Urology · 2009 · 10.1016/j.eururo.2009.08.025

• Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly

  European Urology · 2008 · 10.1016/j.eururo.2008.09.007

• Prospective Validation of Active Surveillance in Prostate Cancer: The PRIAS Study

  European Urology · 2007 · 10.1016/j.eururo.2007.05.011

• Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

  The Journal of Urology · 2006 · 10.1016/j.juro.2006.08.068

• Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program

  Urology · 2002 · 10.1016/s0090-4295(02)01958-1

Current projects

No projects listed.